May 12, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for its Cobalt and Crome implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy-defibrillators (CRT-D),the first Medtronic “high power” devices to offer connected health, including the ability for clinicians to program devices from a physical distance,thereby reducing potential exposure to the virus that causes COVID-19.

May 12, 2020 — Medis acquired Advanced Medical Imaging Development S.r.l. (AMID), a developer and supplier specialized  in cardiovascular mechanics and innovative image processing in ultrasound and other modalities. The strategic acquisition will expedite Medis' expansion in new areas of cardiovascular disease, and secure its access to key technologies to further enhance its innovative portfolio of post-processing solutions for X-ray, MRI, CT, IVUS, OCT and ultrasound devices.

May 11, 2020 – Competitive athletes are a rapidly growing population worldwide. Habitual vigorous exercise, a defining characteristic of this population, can cause various changes in cardiac structure and function known as cardiac remodeling. Clinicians treating these athletes need to be prepared as optimal use of multimodality imaging in competitive athletes requires both an understanding of exercise-induced cardiac remodeling and the strengths and weaknesses of available imaging techniques. 

May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System were presented at Heart Rhythm Society (HRS) 2020 Science virtual meeting. 

May 8, 2020 — Positive 12-month results were announced today from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation Boston Scientific Watchman FLX Left Atrial Appendage Closure (LAAC) Device for patients with non-valvular atrial fibrillation (NVAF).